scholarly journals A systematic review of the effects of oleoylethanolamide, a high‐affinity endogenous ligand of PPAR‐α, on the management and prevention of obesity

2020 ◽  
Vol 47 (4) ◽  
pp. 543-552 ◽  
Author(s):  
Helda Tutunchi ◽  
Maryam Saghafi‐Asl ◽  
Alireza Ostadrahimi
2001 ◽  
Vol 435 (2) ◽  
pp. 142-155 ◽  
Author(s):  
Virginia M. Pickel ◽  
June Chan ◽  
Karen T. Delle Donne ◽  
Hèlène Boudin ◽  
Didier Pélaprat ◽  
...  

1994 ◽  
Vol 143 (2) ◽  
pp. R5-R8 ◽  
Author(s):  
Michael J. Taylor ◽  
Cheryl L. Clark

ABSTRACT Antibody-directed, complement-induced erthrocyte lysis (reverse hemolytic plaque assay) around atrial cardiocytes was used to determine whether this cell type possesses the capacity to secrete the insulin-like hormone relaxin. After 2h of incubation, 33 ± 4% (n = 3) of cardiocytes derived from the atria of neonatal rats secreted detectable amounts of immunoreactive relaxin (i.e. formed plaques) when cultured in monolayers. Increased culture time of cardiocytes failed to increase the fraction of cardiocytes that secreted relaxin. The cumulative amount of relaxin secreted after 3h of incubation (plaque area) was 31% greater (P < 0.05) than the amount of hormone present after lh of incubation, evidence of sustained peptide secretion by cultured cardiocytes. These data suggest that the source of the endogenous ligand for the specific and high-affinity relaxin receptors located in rat atria is the atrial cardiocyte itself. Therefore, relaxin may act via autocrine and/or paracrine routes to regulate cardiovascular structure and/or function.


2011 ◽  
Vol 108 (29) ◽  
pp. 12113-12118 ◽  
Author(s):  
J.-P. Silva ◽  
V. G. Lelianova ◽  
Y. S. Ermolyuk ◽  
N. Vysokov ◽  
P. G. Hitchen ◽  
...  

Endocrinology ◽  
2006 ◽  
Vol 147 (4) ◽  
pp. 1838-1846 ◽  
Author(s):  
Andrew A. Toogood ◽  
Stephen Harvey ◽  
Michael O. Thorner ◽  
Bruce D. Gaylinn

Details of the regulation of GH in birds are unclear. In this report, a receptor was cloned from chicken pituitary cDNA with 61% amino acid sequence identity to the human pituitary GHRH receptor. Phylogenies inferred from sequence alignments support that this is the chicken counterpart of the GHRH receptor known in mammals. Northern blotting shows that this receptor message is expressed in chicken pituitary, with lesser amounts seen in hypothalamus and brain but not in liver. The recombinant chicken receptor binds human GHRH with high affinity and specificity and signals cAMP accumulation. Surprisingly, available peptides synthesized to the published sequence for chicken GHRH-like peptide (cGHRH-LP) were inactive at this receptor. To address this we recloned the cDNA for this cGHRH-LP from chicken hypothalami. The revised sequence encodes lysine at position 21, which is consistent with all reported GHRH sequences from other species but different from the originally published chicken sequence. When this revised cGHRH-LP sequence was synthesized, it had improved but still weak potency at the cloned receptor. Consistent with the activity at the cloned receptor, human GHRH was potent when assayed in live chickens or on chicken pituitary membranes, but cGHRH-LP was not. We conclude that we have cloned a putative GHRH receptor that is homologous to mammalian GHRH receptors and functionally expressed in chicken pituitary, but that the identity of the endogenous ligand remains unclear. The chicken GHRH receptor cloned in this study can serve as a tool to identify its ligand and to clarify the evolutionary development of the regulation of GH.


Sign in / Sign up

Export Citation Format

Share Document